The global DVT Screening Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on DVT Screening Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall DVT Screening Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DVT Screening Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DVT Screening Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
F. Hoffmann-La Roche Ltd.
Generex Biotechnology Lorporation
Laboratorios Farmaceuticos Rovi, S.A.
Pharmathen Pharmaceuticals S.A.
Bristol-Myers Squibb Company
3SBio Inc.
Dupont Pharm Co
Wockhardt Ltd
Bayer AG
Pfizer Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Imaging Modalities
Intravasular Ultrasound
Others

Segment by Application
Hospital
Clinic
Research Centre
Others